York, B., Li, F., Lin, F., Marcelo, K. L., Mao, J., Dean, A., . . . Means, A. R. (2017). Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. Sci Rep.
Chicago Style citaatYork, Brian, et al. "Pharmacological Inhibition of CaMKK2 With the Selective Antagonist STO-609 Regresses NAFLD." Sci Rep 2017.
MLA citatieYork, Brian, et al. "Pharmacological Inhibition of CaMKK2 With the Selective Antagonist STO-609 Regresses NAFLD." Sci Rep 2017.
Let op: Deze citaties zijn niet altijd 100% accuraat.